𝔖 Bobbio Scriptorium
✦   LIBER   ✦

New therapeutic issues in CLL

✍ Scribed by E. Montserrat

Publisher
Springer
Year
1997
Tongue
English
Weight
122 KB
Volume
39
Category
Article
ISSN
1269-3286

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Clinical and statistical issues in thera
Clinical and statistical issues in therapeutic equivalence trials
✍ E. Garbe; J. RΓΆhmel; U. Gundert-Remy πŸ“‚ Article πŸ“… 1993 πŸ› Springer 🌐 English βš– 762 KB

Absolute proof of efficacy can only be given by placebo controlled trials. It is, however, important to classify a drug within the spectrum of existing therapeutic alternatives and, where effective treatment is available, it may be imperative due to ethical considerations to demonstrate that one dru

Ethical issues concerning therapeutic st
Ethical issues concerning therapeutic studies in inflammatory bowel disease
✍ William J. Tremaine; Michael Camilleri πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 71 KB

Physicians often take on responsibilities beyond medical care regarding their patients with ulcerative colitis and Crohn's disease: they serve as the patients' advocates to nonmedical entities and individuals, including insurance companies, schools, employers, companions, and family members. These r

Therapeutic trials in nonalcoholic steat
Therapeutic trials in nonalcoholic steatohepatitis: Insulin sensitizers and related methodological issues
✍ Vlad Ratziu; Stephen Caldwell; Brent A. Neuschwander-Tetri πŸ“‚ Article πŸ“… 2010 πŸ› John Wiley and Sons 🌐 English βš– 146 KB πŸ‘ 1 views

Insulin sensitizers are attractive candidate therapies for nonalcoholic steatohepatitis mainly because of the strong association between this disease and insulin resistance. This review provides a critical overview of the mechanisms of action, clinical trial results, and safety issues of metformin a